Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
231
-
Total 13F shares, excl. options
-
149M
-
Shares change
-
-3.15M
-
Total reported value, excl. options
-
$2.83B
-
Value change
-
-$69M
-
Put/Call ratio
-
0.22
-
Number of buys
-
120
-
Number of sells
-
-110
-
Price
-
$19.09
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q4 2021
295 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q4 2021.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 231 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 149M shares
of 334M outstanding shares and own 44.59% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (12.2M shares), PERCEPTIVE ADVISORS LLC (10.1M shares), WELLINGTON MANAGEMENT GROUP LLP (9.58M shares), Avoro Capital Advisors LLC (8.68M shares), BlackRock Inc. (7.41M shares), ARK Investment Management LLC (7.2M shares), ORBIMED ADVISORS LLC (6.34M shares), FARALLON CAPITAL MANAGEMENT LLC (6.06M shares), STATE STREET CORP (5.09M shares), and Sumitomo Mitsui Trust Holdings, Inc. (4.97M shares).
This table shows the top 231 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.